학술논문
EP1.01-61 iSEND Model as a Predictor of Efficacy in Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer: Fukushima Cohort
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S935-S935
Subject
Language
ISSN
1556-0864